Vaccitech

NASDAQ: VACC · Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM

Vaccitech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-61.07M 5.32M -51.11M
Depreciation & Amortization
5.8M 4.32M 602K
Stock-Based Compensation
4.71M 9.88M 16.49M
Other Working Capital
n/a -831K -63K
Other Non-Cash Items
21.67M -24.09M 8.74M
Deferred Income Tax
-44K -4.34M -119K
Change in Working Capital
n/a -5.52M -7.18M
Operating Cash Flow
-28.94M -14.43M -32.58M
Capital Expenditures
-892K -6.14M -1.15M
Cash Acquisitions
n/a n/a -11.77M
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a 388K n/a
Investing Cash Flow
-892K -5.75M -12.91M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
2.16M 325K 222.74M
Financial Cash Flow
2.16M 325K 222.74M
Net Cash Flow
-29.69M -19.67M 170.79M
Free Cash Flow
-29.83M -20.57M -33.73M